National Bank of Canada FI lifted its position in shares of Genpact Limited (NYSE:G - Free Report) by 759.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 87,141 shares of the business services provider's stock after acquiring an additional 77,007 shares during the quarter. National Bank of Canada FI's holdings in Genpact were worth $3,417,000 at the end of the most recent reporting period.
A number of other large investors also recently added to or reduced their stakes in the business. Jensen Investment Management Inc. boosted its holdings in Genpact by 6.4% during the third quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider's stock worth $7,449,000 after buying an additional 11,410 shares during the last quarter. Vanguard Personalized Indexing Management LLC grew its holdings in Genpact by 53.1% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 49,134 shares of the business services provider's stock valued at $1,580,000 after purchasing an additional 17,034 shares during the period. Nisa Investment Advisors LLC increased its stake in Genpact by 329.6% in the second quarter. Nisa Investment Advisors LLC now owns 10,525 shares of the business services provider's stock valued at $339,000 after purchasing an additional 8,075 shares in the last quarter. Access Investment Management LLC raised its holdings in Genpact by 44.0% in the third quarter. Access Investment Management LLC now owns 212,875 shares of the business services provider's stock worth $8,347,000 after purchasing an additional 65,070 shares during the period. Finally, Retirement Systems of Alabama boosted its position in shares of Genpact by 1.7% during the second quarter. Retirement Systems of Alabama now owns 449,845 shares of the business services provider's stock worth $14,481,000 after purchasing an additional 7,645 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Stock Down 0.1 %
Genpact stock traded down $0.06 during trading hours on Friday, hitting $44.67. The stock had a trading volume of 913,785 shares, compared to its average volume of 1,348,975. The stock's 50-day moving average price is $42.38 and its 200-day moving average price is $37.75. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $47.98. The stock has a market capitalization of $7.88 billion, a P/E ratio of 12.27, a price-to-earnings-growth ratio of 1.56 and a beta of 1.18.
Genpact Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 9th will be paid a dividend of $0.1525 per share. This represents a $0.61 annualized dividend and a yield of 1.37%. The ex-dividend date is Monday, December 9th. Genpact's dividend payout ratio (DPR) is presently 16.76%.
Wall Street Analyst Weigh In
A number of analysts recently commented on the stock. JPMorgan Chase & Co. upped their price objective on shares of Genpact from $35.00 to $43.00 and gave the company a "neutral" rating in a research report on Friday, September 6th. Needham & Company LLC lifted their target price on shares of Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a report on Monday, November 11th. Jefferies Financial Group raised their price objective on Genpact from $35.00 to $40.00 and gave the company a "hold" rating in a research note on Monday, September 9th. Robert W. Baird raised their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research report on Friday, November 8th. Finally, TD Cowen increased their price objective on Genpact from $40.00 to $45.00 and gave the stock a "hold" rating in a research note on Friday, November 8th. Eight equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Genpact presently has a consensus rating of "Hold" and a consensus target price of $42.33.
Get Our Latest Analysis on Genpact
Insider Buying and Selling at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of the business's stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $46.40, for a total value of $417,600.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares of the company's stock, valued at $12,407,545.60. The trade was a 3.26 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 2.80% of the company's stock.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.